Member News

World’s first four dimensional post-COVID lung imagery

Posted 29 September 2021 The world’s first four-dimensional visual insight into the residual effects of COVID-19 or ‘long COVID’ providing an unprecedented ability for patients, clinicians and researchers to understand the ongoing impact of this disease has been…

Cancer Therapeutics Unveils New Identity

Posted 29 September 2021 BioMelbourne Network member Cancer Therapeutics (CTx CRC Ltd) has unveiled its new name and brand identity – Canthera Discovery.  This transformation forms part of a wider organisational strategy to continue the incredible legacy of…

DMX-200 recommended for regulatory approval in COVID-19 study in India

Posted 27 September 2021 Highlights DCGI review complete and study formally recommended for regulatory approval Multiple clinical sites in India initiated Study protocol to recruit 600 participants with COVID-19 overall, with a safety analysis conducted after the first…

AdAlta Granted R&D Rebate funding Facility with Invest Victoria

Posted 22 September 2021 AdAlta granted A$4.0m non-dilutive R&D Rebate funding Facility with Invest Victoria. Facility is one of the first of its kind from Victorian Government. Facility relates to FY2022 R&D and is in addition to existing…

New Swinburne hub co-creating the medical technologies of the future

Posted: 10 September 2021 MedTechVic will bring people with disabilities together with world-leading technology and expertise to create life-changing new medical and enabling technologies. MedTechVic will create the Australian Assistive Technology Living Facility (LivingAT) on Swinburne’s Hawthorn campus,…

SYNthesis Research announces Chief Innovation Officer

Posted 1 September 2021 SYNthesis Research has announced that Dr Martine Keenan will be joining as Chief Innovation Officer. Martine brings to the role exceptional national and international experience in translational drug discovery & development, and the reputation…

4DMedical partners with Asthma Australia

Posted 1 September 2021 Asthma Australia and BioMelbourne Network member 4DMedical have announced a partnership recognising a mutual commitment to promote awareness and improve diagnostic technology for 2.7 million people living with asthma. Asthma is a life-long respiratory…

Partnership to develop new drugs for childhood solid tumours

Posted 29 August 2021 BioMelbourne Network member Oncology One has announced a new partnership with Children’s Cancer Institute to develop new drugs for the treatment of childhood solid tumours. The partnership is focused on the development of novel…

ANDHealth Receives $19.75M From Medical Research Future Fund

Posted 20 August 2021 ANDHealth, Australia’s leading digital health commercialisation organisation, has today announced it has been successful in securing $19.75M in funding received from the Australian Federal Government under the Medical Research Future Fund (MRFF) Early Stage…

Imagion Biosystems enters agreement for treating breast cancer

Posted 16 August 2021 BioMelbourne member Imagion Biosystems Limited, a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to announce it has entered into a Joint Development Agreement with Global Cancer Technology (GCT),…

4DMedical signs commercial contract with pharmaceutical company 

Posted 9 August 2021 Respiratory imaging disruptor and BioMelbourne Network member 4DMedical today announced the signing of a commercial contract with Novartis. Under the terms of the agreement, XV Ventilation Reports will be provided to Novartis on a…

BioCurate and Monash accelerate research into treatments for breast cancer

Posted: 2 August 2021 The first award under BioCurate’s new “Proof of Concept” fund has been granted to the Monash Biomedicine Discovery Institute (BDI). This award will support the key research needed to determine the effectiveness of targeting…

Home

News & opinion

Member Directory

Events